Protein in prostate tissue 'indicates increased cancer risk'
Researchers have discovered that men who have a specific protein present in prostate tissue biopsies may be at increased risk of developing prostate cancer. This is according to a study published in the Journal of Clinical Oncology.The American Cancer Society estimates that around 238,590 new cases of prostate cancer will have been diagnosed in the US throughout 2013.
Targeting evolving cancer stem cells in prostate cancer
UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.
Risk of lethal prostate cancer in overweight patients increased by genetic mutation
Obesity is associated with a worse prostate cancer prognosis among men whose tumors contain a specific genetic mutation, suggest results from a new study led by Harvard School of Public Health (HSPH), Dana-Farber Cancer Institute and Brigham and Women's Hospital researchers.
Risk factors identified for ureteral injury during robot-assisted prostate surgery
There may be warning signs to help surgeons avoid damaging part of the urinary system during robot-assisted surgical removal of prostate cancer, ultimately preventing the expense of additional surgery, according to researchers at Henry Ford's Vattikuti Urology Institute.
Aggressive prostate cancer charted by novel study
Many patients diagnosed with prostate cancer have indolent, slow-growing forms of the disease that are not life-threatening. However, more than 30,000 American men will die from aggressive prostate cancer this year alone.
Low-fat diet, omega-3 linked to reduced prostate cancer aggression
A follow-up study reveals that men suffering from prostate cancer who took fish oil supplements alongside a low-fat diet demonstrated changes in their cancer tissue that may indicate reduced cancer aggression. This is according to research published in the journal Cancer Prevention Research.Prostate cancer is the most common cancer among American men.
Geranylgeraniol suppresses the viability of human prostate cancer cells and HMG CoA reductase
Researchers at Texas Woman's University have shown that a diterpene geranylgeraniol found in linseed oil, Cedrela toona wood oil, sucupira branca fruit oil and more recently, annatto seed oil, suppressed the viability of human DU145 prostate carcinoma cells via cell cycle arrest at the G1 phase and the initiation of apoptosis.
Success of radiation delivery may be affected by balloon positioning during prostate cancer treatment
A University of Colorado Cancer Center study recently published in the journal Physics in Medicine and Biology shows that endorectal balloons commonly used during precise radiation treatment for prostate cancer can deform the prostate in a way that could make radiation miss its mark."Use of a balloon allows you to stabilize the anatomy.
Multi-site study further demonstrate efficacy and quality of life benefits for prostate cancer patients treated with Accuray's Cyberknife® System
Accuray Incorporated (Nasdaq: ARAY), has announced the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles(UCLA).
Phase 3 trial of XTANDI™ in chemotherapy-naive patients meets both co-primary endpoints
Astellas Pharma Inc. and Medivation, Inc. have announced that the Independent Data Monitoring Committee (IDMC) has informed the companies of positive results from a planned interim analysis of the Phase 3 PREVAIL trial of XTANDI (enzalutamide) in more than 1,700 men with metastatic castration-resistant prostate cancer (mCRPC) that has progressed despite androgen deprivation therapy and who have...